PLAT and stroke disorder: The only widely approved pharmacologic therapy for AIS is tissue-type plasminogen activator (tPA; Alteplase®, Activase®, Actilyse®), which is approved for use within 3 h since known onset of stroke symptoms [4], although many national guidelines allow for administration of tPA up to 4.5 h after stroke onset [5].